Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Ungar

Showing results (91-100 of 127) with videos related to

Pageof 13
Sort By:
The Journal of Allergy and Clinical Immunology|April 27, 2026
Comprehensive molecular profiling of Hispanic, Black, Asian, and White atopic dermatitis via tape strip RNAseq and serum proteomicsDaniel Liu, Ester Del Duca, Patrick Brunner, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|March 10, 2026
Hematologic Patterns in Differentiating DRESS From Morbilliform Drug Eruptions: A Preliminary InvestigationGrace Rabinowitz, Austin Piontkowski, Benjamin Shwartzman, et al.
American Journal of Clinical Dermatology|January 27, 2026
Long-Term Real-World Evaluation of Abrocitinib in Moderate-to-Severe Atopic Dermatitis Across a Diverse Patient Population in a Multi-site Hospital SystemMegan Lau, Joseph Largen, Jasmine Levine, et al.
The Journal of Allergy and Clinical Immunology|February 28, 2017
Molecular signatures order the potency of topically applied anti-inflammatory drugs in patients with atopic dermatitisEmma Guttman-Yassky, Benjamin Ungar, Kunal Malik, et al.
Journal of the American Academy of Dermatology|November 1, 2019
The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signatureAna B Pavel, Lisa Zhou, Aisleen Diaz, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 30, 2020
A Preliminary <sup>18</sup>F-FDG-PET/MRI Study Shows Increased Vascular Inflammation in Moderate-to-Severe Atopic DermatitisBenjamin Ungar, Ana B Pavel, Philip M Robson, et al.
Allergy|October 1, 2022
The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patientsBenjamin Ungar, Susan Hartzell, Daniel Lozano-Ojalvo, et al.
The Journal of Allergy and Clinical Immunology|January 9, 2015
Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissectionHitokazu Esaki, David A Ewald, Benjamin Ungar, et al.
Allergy|March 13, 2026
Non-Invasive Scalp Tape-Strip RNA Sequencing Captures Disease Activity and Treatment-Response Signatures in Alopecia AreataCarmen Mochón-Jiménez, Jesús Gay-Mimbrera, Viviana Dávila-Flores, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 29, 2022
No association between dupilumab use and short-term cancer development in atopic dermatitis patientsShayan Owji, Benjamin Ungar, Danielle P Dubin, et al.
Pageof 13

Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
The Journal of Allergy and Clinical Immunology|April 27, 2026
Comprehensive molecular profiling of Hispanic, Black, Asian, and White atopic dermatitis via tape strip RNAseq and serum proteomicsDaniel Liu, Ester Del Duca, Patrick Brunner, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|March 10, 2026
Hematologic Patterns in Differentiating DRESS From Morbilliform Drug Eruptions: A Preliminary InvestigationGrace Rabinowitz, Austin Piontkowski, Benjamin Shwartzman, et al.
American Journal of Clinical Dermatology|January 27, 2026
Long-Term Real-World Evaluation of Abrocitinib in Moderate-to-Severe Atopic Dermatitis Across a Diverse Patient Population in a Multi-site Hospital SystemMegan Lau, Joseph Largen, Jasmine Levine, et al.
The Journal of Allergy and Clinical Immunology|February 28, 2017
Molecular signatures order the potency of topically applied anti-inflammatory drugs in patients with atopic dermatitisEmma Guttman-Yassky, Benjamin Ungar, Kunal Malik, et al.
Journal of the American Academy of Dermatology|November 1, 2019
The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signatureAna B Pavel, Lisa Zhou, Aisleen Diaz, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 30, 2020
A Preliminary <sup>18</sup>F-FDG-PET/MRI Study Shows Increased Vascular Inflammation in Moderate-to-Severe Atopic DermatitisBenjamin Ungar, Ana B Pavel, Philip M Robson, et al.
Allergy|October 1, 2022
The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patientsBenjamin Ungar, Susan Hartzell, Daniel Lozano-Ojalvo, et al.
The Journal of Allergy and Clinical Immunology|January 9, 2015
Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissectionHitokazu Esaki, David A Ewald, Benjamin Ungar, et al.
Allergy|March 13, 2026
Non-Invasive Scalp Tape-Strip RNA Sequencing Captures Disease Activity and Treatment-Response Signatures in Alopecia AreataCarmen Mochón-Jiménez, Jesús Gay-Mimbrera, Viviana Dávila-Flores, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 29, 2022
No association between dupilumab use and short-term cancer development in atopic dermatitis patientsShayan Owji, Benjamin Ungar, Danielle P Dubin, et al.
Pageof 13